Electromed saw its IBD SmartSelect Composite Rating jump to 96 Thursday, up from 94 the day before.
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The best stocks tend to have a 95 or better grade as they launch a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Electromed is now out of buy range after breaking out from an 18.60 buy point in a cup without handle. Keep in mind that it's a thinly traded stock, with average daily dollar volume under $8 million.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The stock has an 87 EPS Rating, which means its recent quarterly and longer-term annual earnings growth is outpacing 87% of all stocks.
Its Accumulation/Distribution Rating of E shows heavy selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.
In Q2, the company reported 16% earnings growth. Sales were flat, matching the prior quarter's 19%.
Electromed earns the No. 2 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
